OncLive and Tulane Cancer Center at the Tulane University School of Medicine have joined forces to promote awareness of new developments in cancer care through OncLive's Strategic Alliance Partnership program, OncLive announced today.
PLAINSBORO, N.J. (Feb. 17, 2015) — OncLive® and Tulane Cancer Center at the Tulane University School of Medicine have joined forces to promote awareness of new developments in cancer care through OncLive’s Strategic Alliance Partnership program, OncLive announced today.Through the Strategic Alliance Partnership program, the OncLive editorial and marketing teams will work with Tulane Cancer Center to highlight the center’s patient-focused, research-driven cancer care.
The Tulane Cancer Center is home to world-class teams in key cancer research specialties, including prostate cancer, genetic instability, health disparities, circadian rhythm disruption, viruses and cancer, and cancer drug discovery. The center’s “lab bench to bedside” philosophy helps transform research discoveries into better treatment options for patients. Tulane Cancer Center offers patients access to clinical trials of cutting-edge investigative treatment options that are not yet widely available but are often the precursors to the therapies of tomorrow.
With this alliance, OncLive gains the ability to give healthcare professionals and patients direct, timely access to important news about cancer research and patient care from Tulane Cancer Center, as it already does with more than 30 other leading cancer centers, nursing schools and physician groups.
Prescott Deininger, Ph.D., director of Tulane Cancer Center said, “Our work at Tulane is driven by an urgent need to address the unacceptably high rate of cancer mortality in our region. Through our partnership with OncLive, we look forward to sharing our work with others across the world who are fighting the same battle.”
Mike J. Hennessy Jr., senior vice president, oncology & specialty pharmacy, said, “We are excited to partner with Tulane Cancer Center to report on important research discoveries and clinical practices that could impact the broader healthcare and patient communities confronting cancer. Collaborating and sharing these new developments puts everyone in a better position to make strides toward a world without this deplorable disease.”
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. OncLive offers oncology professionals with resources and information to provide the best care for their patients. Intellisphere, LLC, a leading provider of health care publishing, research, and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, NJ. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE™ magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers, and advocacy groups. To learn more, please visit www.OncLive.com.
About Tulane Cancer Center
The Tulane Cancer Center was founded in 1993 as a resource for supporting cancer-focused basic research and clinical faculty from home departments across Tulane University. Tulane Cancer Center’s research endeavors have established a pipeline to translate key laboratory discoveries into improved treatment options for patients. As an academic cancer center, Tulane offers patients a multidisciplinary approach as well as access to cutting-edge investigational treatment and prevention trials. Through focused mentorship and training, the center has also prioritized preparation and education of the next generation of cancer researchers and physician scientists. To learn more, please visit http://tulane.edu/som/cancer/.
For Tulane Cancer Center:
Melanie N. Cross, 504-988-6592, firstname.lastname@example.org
Becky Taylor, 609-240-6886, email@example.com